S&P 500   4,005.31 (+0.06%)
DOW   32,522.89 (-0.12%)
QQQ   311.23 (+0.29%)
AAPL   160.21 (+0.58%)
MSFT   276.09 (+0.84%)
META   202.75 (+0.29%)
GOOGL   104.89 (-0.03%)
AMZN   100.07 (-0.54%)
TSLA   197.96 (+0.19%)
NVDA   269.07 (+2.70%)
NIO   9.42 (+1.62%)
BABA   85.22 (+1.82%)
AMD   96.81 (+0.92%)
T   18.56 (+0.11%)
F   11.89 (+1.45%)
MU   58.83 (+0.34%)
CGC   1.97 (+-0.01%)
GE   92.24 (+0.07%)
DIS   96.42 (-0.12%)
AMC   4.57 (+3.63%)
PFE   40.57 (-0.22%)
PYPL   75.78 (-1.23%)
NFLX   301.32 (-1.46%)
S&P 500   4,005.31 (+0.06%)
DOW   32,522.89 (-0.12%)
QQQ   311.23 (+0.29%)
AAPL   160.21 (+0.58%)
MSFT   276.09 (+0.84%)
META   202.75 (+0.29%)
GOOGL   104.89 (-0.03%)
AMZN   100.07 (-0.54%)
TSLA   197.96 (+0.19%)
NVDA   269.07 (+2.70%)
NIO   9.42 (+1.62%)
BABA   85.22 (+1.82%)
AMD   96.81 (+0.92%)
T   18.56 (+0.11%)
F   11.89 (+1.45%)
MU   58.83 (+0.34%)
CGC   1.97 (+-0.01%)
GE   92.24 (+0.07%)
DIS   96.42 (-0.12%)
AMC   4.57 (+3.63%)
PFE   40.57 (-0.22%)
PYPL   75.78 (-1.23%)
NFLX   301.32 (-1.46%)
S&P 500   4,005.31 (+0.06%)
DOW   32,522.89 (-0.12%)
QQQ   311.23 (+0.29%)
AAPL   160.21 (+0.58%)
MSFT   276.09 (+0.84%)
META   202.75 (+0.29%)
GOOGL   104.89 (-0.03%)
AMZN   100.07 (-0.54%)
TSLA   197.96 (+0.19%)
NVDA   269.07 (+2.70%)
NIO   9.42 (+1.62%)
BABA   85.22 (+1.82%)
AMD   96.81 (+0.92%)
T   18.56 (+0.11%)
F   11.89 (+1.45%)
MU   58.83 (+0.34%)
CGC   1.97 (+-0.01%)
GE   92.24 (+0.07%)
DIS   96.42 (-0.12%)
AMC   4.57 (+3.63%)
PFE   40.57 (-0.22%)
PYPL   75.78 (-1.23%)
NFLX   301.32 (-1.46%)
S&P 500   4,005.31 (+0.06%)
DOW   32,522.89 (-0.12%)
QQQ   311.23 (+0.29%)
AAPL   160.21 (+0.58%)
MSFT   276.09 (+0.84%)
META   202.75 (+0.29%)
GOOGL   104.89 (-0.03%)
AMZN   100.07 (-0.54%)
TSLA   197.96 (+0.19%)
NVDA   269.07 (+2.70%)
NIO   9.42 (+1.62%)
BABA   85.22 (+1.82%)
AMD   96.81 (+0.92%)
T   18.56 (+0.11%)
F   11.89 (+1.45%)
MU   58.83 (+0.34%)
CGC   1.97 (+-0.01%)
GE   92.24 (+0.07%)
DIS   96.42 (-0.12%)
AMC   4.57 (+3.63%)
PFE   40.57 (-0.22%)
PYPL   75.78 (-1.23%)
NFLX   301.32 (-1.46%)
OTCMKTS:EPGNY

Epigenomics - EPGNY Stock Forecast, Price & News

$2.39
0.00 (0.00%)
(As of 03/21/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.39
$2.39
50-Day Range
$2.39
$9.56
52-Week Range
$2.01
$2.39
Volume
N/A
Average Volume
100 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

EPGNY stock logo

About Epigenomics (OTCMKTS:EPGNY) Stock

Epigenomics AG, a molecular diagnostics company, focuses on liquid biopsy for the early detection of cancer. Its lead product is Epi proColon, a blood-based test for the early detection of colorectal cancer in the United States, Europe, and China. The company's products also include hepatocellular carcinoma blood test; Epi proColon, a liquid biopsy test for detection of colorectal cancer; and Epi BiSKit, a pre-analytical tool, which provides a set of reagents for the preparation of bisulfite-converted DNA. Its research and development activities identify suitable biomarkers in human tissue and developing and patenting the corresponding in vitro diagnostic blood tests. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany.

Receive EPGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter.

EPGNY Stock News Headlines

Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
Stocks Positioned For The Year
This breakthrough stock has bright future this decade.
EQS-Adhoc: Epigenomics Releases Performance Data on Next Generation Test
Epigenomics Releases Performance Data on Next Generation Test
EQS-News: Epigenomics Releases Performance Data on Next Generation Test
DGAP-Adhoc: Epigenomics AG: Capital reduction planned at a ratio of 4 : 1
EPGNY After-Hours Quotes
EPGNY Real-Time Quotes
See More Headlines
Receive EPGNY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Epigenomics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:EPGNY
CIK
N/A
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Gregory K. Hamilton (Age 52)
    CEO & Member of the Exec. Board
    Comp: $828.44k
  • Dr. Andrew A. Lukowiak Ph.D. (Age 50)
    Pres & Chief Scientific Officer
    Comp: $387.44k
  • Mr. Jens Ravens (Age 52)
    CFO & Member of Exec. Board
  • Frederic Hilke
    Investor Relations Officer
  • Dr. Noel Thomas Doheny
    Chief Exec. Officer of Epigenomics Inc.













EPGNY Stock - Frequently Asked Questions

How have EPGNY shares performed in 2023?

Epigenomics' stock was trading at $9.56 at the beginning of 2023. Since then, EPGNY stock has decreased by 75.0% and is now trading at $2.39.
View the best growth stocks for 2023 here
.

What is Epigenomics' stock symbol?

Epigenomics trades on the OTCMKTS under the ticker symbol "EPGNY."

How do I buy shares of Epigenomics?

Shares of EPGNY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Epigenomics' stock price today?

One share of EPGNY stock can currently be purchased for approximately $2.39.

How can I contact Epigenomics?

Epigenomics' mailing address is Geneststrasse 5, Berlin, Berlin 10829. The official website for the company is www.epigenomics.com. The company can be reached via phone at (493) 024-3450.

This page (OTCMKTS:EPGNY) was last updated on 3/22/2023 by MarketBeat.com Staff